Track topics on Twitter Track topics that are important to you
Two new CRISPR-Cas9 variants, SpG and SpRY, enable unconstrained targeting across nearly the entire genome and with single base pair precision. SpG is capable of targeting an expanded set of NGN PAMs, and SpRY is hardly dependent at all on adjacent PAMs. The developers of SpRY report that it could be used to correct mutations associated with human diseases located in previously uneditable regions of the genome.NEXT ARTICLE
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...